The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Characterization of patients who received prior chemotherapy for advanced breast cancer (ABC) in BOLERO-2.
Denise Aysel Yardley
Consultant or Advisory Role - Novartis
Mario Campone
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Fabienne Lebrun
No relevant relationships to disclose
Shinzaburo Noguchi
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; GlaxoSmithKline; Novartis; Pfizer; Sanofi ; Taiho Pharmaceutical; Takeda
Other Remuneration - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; GlaxoSmithKline; Novartis; Pfizer; Sanofi ; Taiho Pharmaceutical; Takeda
Kathleen I. Pritchard
Consultant or Advisory Role - Abraxis BioScience; Amgen; AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Roche; Sanofi
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Roche; Sanofi
Research Funding - National Cancer Institute of Canada Clinical Trials Group
Expert Testimony - AstraZeneca; GlaxoSmithKline; Sanofi
Other Remuneration - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Ortho Biotech; Pfizer; Sanofi
Howard A. Burris
No relevant relationships to disclose
J. Thaddeus Beck
No relevant relationships to disclose
Yoshinori Ito
No relevant relationships to disclose
Thomas Bachelot
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Barbara Pistilli
Honoraria - Novartis
Bohuslav Melichar
Honoraria - Novartis
Katarina Petrakova
No relevant relationships to disclose
Francis P. Arena
Research Funding - Novartis
Frans Erdkamp
Consultant or Advisory Role - Amgen; Novartis; Roche; Sanofi
Wael A. Harb
Other Remuneration - Horizon Oncology Research
Jennifer Keating Litton
Research Funding - Bristol-Myers Squibb; Novartis
Thomas Brechenmacher
Employment or Leadership Position - Novartis
Mona El-Hashimy
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Tanya Taran
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Michael Gnant
Consultant or Advisory Role - Merrion; Novartis
Honoraria - Amgen; AstraZeneca; Bayer; Genomic Health; GlaxoSmithKline; Novartis; Pfizer; Sandoz
Research Funding - GlaxoSmithKline; Novartis; Roche; Sanofi
Other Remuneration - Amgen; AstraZeneca; Bayer; Genomic Health; GlaxoSmithKline; Novartis; Pfizer; Sandoz